Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy

SIMPLE SUMMARY: This review was aimed at exploring the potentiality of drugging the endocannabinoid system as a therapeutic option for Alzheimer’s disease (AD). Recent discoveries have demonstrated how the modulation of cannabinoid receptor 1 (CB1) and receptor 2 (CB2) can exert neuroprotective effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Abate, Giulia, Uberti, Daniela, Tambaro, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234911/
https://www.ncbi.nlm.nih.gov/pubmed/34204237
http://dx.doi.org/10.3390/biology10060542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234911/
https://www.ncbi.nlm.nih.gov/pubmed/34204237
http://dx.doi.org/10.3390/biology10060542

Ejemplares similares